| R-HSA-1168372 |
Downstream signaling events of B Cell Receptor (BCR) |
| R-HSA-1169091 |
Activation of NF-kappaB in B cells |
| R-HSA-1170546 |
Prolactin receptor signaling |
| R-HSA-1280215 |
Cytokine Signaling in Immune system |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-157118 |
Signaling by NOTCH |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-1640170 |
Cell Cycle |
| R-HSA-1643685 |
Disease |
| R-HSA-166016 |
Toll Like Receptor 4 (TLR4) Cascade |
| R-HSA-166058 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane |
| R-HSA-166166 |
MyD88-independent TLR4 cascade |
| R-HSA-168138 |
Toll Like Receptor 9 (TLR9) Cascade |
| R-HSA-168142 |
Toll Like Receptor 10 (TLR10) Cascade |
| R-HSA-168164 |
Toll Like Receptor 3 (TLR3) Cascade |
| R-HSA-168176 |
Toll Like Receptor 5 (TLR5) Cascade |
| R-HSA-168179 |
Toll Like Receptor TLR1:TLR2 Cascade |
| R-HSA-168181 |
Toll Like Receptor 7/8 (TLR7/8) Cascade |
| R-HSA-168188 |
Toll Like Receptor TLR6:TLR2 Cascade |
| R-HSA-168249 |
Innate Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-168898 |
Toll-like Receptor Cascades |
| R-HSA-174113 |
SCF-beta-TrCP mediated degradation of Emi1 |
| R-HSA-174143 |
APC/C-mediated degradation of cell cycle proteins |
| R-HSA-176408 |
Regulation of APC/C activators between G1/S and early anaphase |
| R-HSA-181438 |
Toll Like Receptor 2 (TLR2) Cascade |
| R-HSA-187577 |
SCF(Skp2)-mediated degradation of p27/p21 |
| R-HSA-195253 |
Degradation of beta-catenin by the destruction complex |
| R-HSA-195721 |
Signaling by WNT |
| R-HSA-1980143 |
Signaling by NOTCH1 |
| R-HSA-202403 |
TCR signaling |
| R-HSA-202424 |
Downstream TCR signaling |
| R-HSA-2122947 |
NOTCH1 Intracellular Domain Regulates Transcription |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-2454202 |
Fc epsilon receptor (FCERI) signaling |
| R-HSA-2565942 |
Regulation of PLK1 Activity at G2/M Transition |
| R-HSA-2644602 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer |
| R-HSA-2644603 |
Signaling by NOTCH1 in Cancer |
| R-HSA-2644605 |
FBXW7 Mutants and NOTCH1 in Cancer |
| R-HSA-2644606 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants |
| R-HSA-2644607 |
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling |
| R-HSA-2871837 |
FCERI mediated NF-kB activation |
| R-HSA-2894858 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer |
| R-HSA-2894862 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants |
| R-HSA-382551 |
Transport of small molecules |
| R-HSA-392499 |
Metabolism of proteins |
| R-HSA-400253 |
Circadian Clock |
| R-HSA-446652 |
Interleukin-1 family signaling |
| R-HSA-448424 |
Interleukin-17 signaling |
| R-HSA-449147 |
Signaling by Interleukins |
| R-HSA-450294 |
MAP kinase activation |
| R-HSA-453274 |
Mitotic G2-G2/M phases |
| R-HSA-453276 |
Regulation of mitotic cell cycle |
| R-HSA-453279 |
Mitotic G1 phase and G1/S transition |
| R-HSA-5358351 |
Signaling by Hedgehog |
| R-HSA-5358351 |
Signaling by Hedgehog |
| R-HSA-5607761 |
Dectin-1 mediated noncanonical NF-kB signaling |
| R-HSA-5607764 |
CLEC7A (Dectin-1) signaling |
| R-HSA-5610780 |
Degradation of GLI1 by the proteasome |
| R-HSA-5610783 |
Degradation of GLI2 by the proteasome |
| R-HSA-5610785 |
GLI3 is processed to GLI3R by the proteasome |
| R-HSA-5610787 |
Hedgehog 'off' state |
| R-HSA-5610787 |
Hedgehog 'off' state |
| R-HSA-5621481 |
C-type lectin receptors (CLRs) |
| R-HSA-5663202 |
Diseases of signal transduction by growth factor receptors and second messengers |
| R-HSA-5668541 |
TNFR2 non-canonical NF-kB pathway |
| R-HSA-5676590 |
NIK-->noncanonical NF-kB signaling |
| R-HSA-5684264 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation |
| R-HSA-597592 |
Post-translational protein modification |
| R-HSA-68949 |
Orc1 removal from chromatin |
| R-HSA-69052 |
Switching of origins to a post-replicative state |
| R-HSA-69202 |
Cyclin E associated events during G1/S transition |
| R-HSA-69206 |
G1/S Transition |
| R-HSA-69231 |
Cyclin D associated events in G1 |
| R-HSA-69236 |
G1 Phase |
| R-HSA-69239 |
Synthesis of DNA |
| R-HSA-69242 |
S Phase |
| R-HSA-69275 |
G2/M Transition |
| R-HSA-69278 |
Cell Cycle, Mitotic |
| R-HSA-69306 |
DNA Replication |
| R-HSA-69656 |
Cyclin A:Cdk2-associated events at S phase entry |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-8854050 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis |
| R-HSA-8878166 |
Transcriptional regulation by RUNX2 |
| R-HSA-8878166 |
Transcriptional regulation by RUNX2 |
| R-HSA-8939902 |
Regulation of RUNX2 expression and activity |
| R-HSA-8939902 |
Regulation of RUNX2 expression and activity |
| R-HSA-8951664 |
Neddylation |
| R-HSA-9013694 |
Signaling by NOTCH4 |
| R-HSA-9020702 |
Interleukin-1 signaling |
| R-HSA-917937 |
Iron uptake and transport |
| R-HSA-937061 |
TRIF(TICAM1)-mediated TLR4 signaling |
| R-HSA-9604323 |
Negative regulation of NOTCH4 signaling |
| R-HSA-975138 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
| R-HSA-975155 |
MyD88 dependent cascade initiated on endosome |
| R-HSA-975871 |
MyD88 cascade initiated on plasma membrane |
| R-HSA-983168 |
Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-983169 |
Class I MHC mediated antigen processing & presentation |
| R-HSA-983705 |
Signaling by the B Cell Receptor (BCR) |
